当前位置:首页 - 行情中心 - 益佰制药(600594) - 财务分析

益佰制药

(600594)

  

流通市值:24.32亿  总市值:24.32亿
流通股本:7.84亿   总股本:7.84亿

益佰制药(600594)财务分析

利润表
报告期2026-09-302026-06-302026-03-312025-12-31
营业总收入989,980,001.03689,387,704.62358,837,040.951,862,920,853.13
营业总成本1,110,706,131.69742,482,846.67374,652,779.962,001,366,895.95
其他经营收益
营业利润-142,137,191.98-74,186,475.64-21,904,407.07-303,982,173.75
利润总额-141,435,110.41-73,072,664.02-20,875,480.6-311,748,335.7
净利润-148,237,463.8-78,460,579.89-28,963,288.04-335,341,885.11
每股收益
其他综合收益-5,227.47,181.75--164,440.9
综合收益总额-148,242,691.2-78,453,398.14-28,963,288.04-335,506,326.01
资产负债表
报告期2026-09-302026-06-302026-03-312025-12-31
流动资产:
流动资产合计1,263,583,964.281,345,071,697.571,443,079,324.151,447,717,750.36
非流动资产:
非流动资产合计1,896,650,446.661,921,889,296.681,955,146,882.671,994,117,912.4
资产总计3,160,234,410.943,266,960,994.253,398,226,206.823,441,835,662.76
流动负债:
流动负债合计818,156,158.48791,828,999.24847,950,870.93908,875,452.96
非流动负债:
非流动负债合计225,716,968.22282,981,417.71308,634,412.64262,356,234.36
负债合计1,043,873,126.71,074,810,416.951,156,585,283.571,171,231,687.32
所有者权益(或股东权益):
归属于母公司股东权益合计2,036,531,155.152,107,456,243.012,158,262,207.322,187,786,874.36
股东权益合计2,116,361,284.242,192,150,577.32,241,640,923.252,270,603,975.44
负债和股东权益合计3,160,234,410.943,266,960,994.253,398,226,206.823,441,835,662.76
现金流量表
报告期2026-09-302026-06-302026-03-312025-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,199,051,713.36846,173,803.66447,069,789.962,244,956,178.86
经营活动现金流出小计1,118,684,198.57782,032,289.31401,891,726.591,988,250,966.52
经营活动产生的现金流量净额80,367,514.7964,141,514.3545,178,063.37256,705,212.34
投资活动产生的现金流量:
投资活动现金流入小计21,169,427.3896,325.59817,934.596,988,631.89
投资活动现金流出小计58,560,114.7333,612,774.017,595,763.1334,992,693.77
投资活动产生的现金流量净额-37,390,687.43-32,716,448.42-6,777,828.54-28,004,061.88
筹资活动产生的现金流量:
筹资活动现金流入小计430,000,000380,000,000255,000,000515,999,999.5
筹资活动现金流出小计517,403,189.16428,311,862.72250,627,961.3818,566,887.27
筹资活动产生的现金流量净额-87,403,189.16-48,311,862.724,372,038.7-302,566,887.77
汇率变动对现金及现金等价物的影响-17,355.41-13,286.08-7,856.67-8,941.59
现金及现金等价物净增加额-44,443,717.21-16,900,082.8742,764,416.86-73,874,678.9
期末现金及现金等价物余额400,688,913.76428,232,548.1487,897,047.83445,132,630.97
补充资料:
现金及现金等价物的净增加额--16,900,082.87--73,874,678.9
TOP↑